• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN PUMP; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN PUMP; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 14000
Device Problem Insufficient Information (3190)
Patient Problems Hyperglycemia (1905); High Blood Pressure/ Hypertension (1908); Renal Failure (2041); Diabetic Ketoacidosis (2364); Coma (2417)
Event Date 11/01/2020
Event Type  Injury  
Manufacturer Narrative
According to the complainant the device will not be returned for investigation.We are unable to determine if any product condition could have contributed to the reported hospitalization and diabetic ketoacidosis.No lot release records were reviewed, as the product lot number was not provided.
 
Event Description
It was reported that the patient had been hospitalized with diabetic ketoacidosis (dka).The patient's blood glucose levels reached 1005 mg/dl while wearing the pod.Symptoms reported include hyperglycemia, shortness of breath and high ketones.Spouse reported patient had a stroke while in the emergency room and was placed in the intensive care unit for the first 3 days of hospitalization.Patient also experienced hypertension and kidney failure.Patient was then put on a respirator, ventilator, treated with an insulin drip, given dialysis every other day with a catheter, and given high blood pressure medication.Spouse reported patient was in a diabetic coma as well.The patient was also prescribed the medications listed below.The patient was released after spending 11 days in the hospital.The pod was removed and discarded at the hospital.The list of medications prescribed to the patient is as follows: medication strength frequency: pantoprazole 40mg, norvasc 5mg daily, folic acid once daily, calcium magnesium 1250mg once daily, albuterol 3ml every 6 hours, admelog insulin for pod.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN PUMP
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
jordan biswurm
100 nagog park
acton, MA 01720
9786007000
MDR Report Key10931065
MDR Text Key220470512
Report Number3004464228-2020-18628
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385081120002
UDI-Public(01)20385081120002
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K122953
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number14000
Device Catalogue NumberZXP425
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/18/2020
Initial Date FDA Received12/01/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age57 YR
-
-